Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Related Articles by Review for PubMed (Select 18491401)

1.

Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.

Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC.

Int J Cancer. 2008 Aug 15;123(4):867-73. doi: 10.1002/ijc.23529.

PMID:
18491401
2.

Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.

Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD; Knowledge NETwork.

Endocr Relat Cancer. 2014 May 6;21(3):R153-63. doi: 10.1530/ERC-13-0125. Print 2014 Jun. Review.

3.

[Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection].

Scherübl H, Faiss S, Jahn HU, Liehr RM, Schwertner C, Steinberg J, Stölzel U, Weinke T, Zimmer T, Klöppel G.

Dtsch Med Wochenschr. 2009 Jul;134(30):1529-35. doi: 10.1055/s-0029-1233975. Epub 2009 Jul 14. Review. German.

PMID:
19603370
4.

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöppel G.

Endoscopy. 2010 Aug;42(8):664-71. doi: 10.1055/s-0030-1255564. Epub 2010 Jul 28. Review.

PMID:
20669078
5.

[Neuroendocrine tumors of the small bowels are on the rise: early tumors and their management].

Scherübl H, Schwertner C, Steinberg J, Stölzel U, Pohl J, Dralle H, Klöppel G.

Z Gastroenterol. 2010 Mar;48(3):406-13. doi: 10.1055/s-0028-1109862. Epub 2010 Feb 24. Review. German.

PMID:
20183784
6.

Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Permuth-Wey J, Egan KM.

Fam Cancer. 2009;8(2):109-17. doi: 10.1007/s10689-008-9214-8. Epub 2008 Sep 2. Review.

PMID:
18763055
7.

Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy.

Gustafsson BI, Siddique L, Chan A, Dong M, Drozdov I, Kidd M, Modlin IM.

Int J Oncol. 2008 Dec;33(6):1121-31. Review.

PMID:
19020744
8.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB.

J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. Review.

PMID:
18565894
9.

The epidemiology of cancer of the small bowel.

Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N.

Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):243-51. Review.

10.

Differences in cancer incidence and mortality among socio-economic groups.

van Loon AJ, Brug J, Goldbohm RA, van den Brandt PA, Burg J [corrected to Brug J].

Scand J Soc Med. 1995 Jun;23(2):110-20. Review. Erratum in: Scand J Soc Med 1995 Sep;23(3):155.

PMID:
7676217
11.

Epidemiology and risk factors in pancreatic cancer.

Ahlgren JD.

Semin Oncol. 1996 Apr;23(2):241-50. Review.

PMID:
8623060
12.

Epidemiology of gastroenteropancreatic neuroendocrine tumours.

Fraenkel M, Kim MK, Faggiano A, Valk GD.

Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):691-703. doi: 10.1016/j.bpg.2013.01.006. Review.

PMID:
23582913
13.

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB 3rd, Pommier RF; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):767-74. doi: 10.1097/MPA.0b013e3181ec1261.

PMID:
20664474
14.

Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.

Hoffmann KM, Furukawa M, Jensen RT.

Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):675-97. Review.

PMID:
16253893
15.

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM.

Endocrinol Metab Clin North Am. 2011 Mar;40(1):1-18, vii. doi: 10.1016/j.ecl.2010.12.005. Review.

PMID:
21349409
16.

Genetics of neuroendocrine and carcinoid tumours.

Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV.

Endocr Relat Cancer. 2003 Dec;10(4):437-50. Review.

17.

Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours.

Ferolla P, Faggiano A, Avenia N, Milone F, Masone S, Giampaglia F, Puma F, Daddi G, Angeletti G, Lombardi G, Santeusanio F, Colao A.

Clin Endocrinol (Oxf). 2007 Jan;66(1):1-6. Review.

PMID:
17201794
18.
19.

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.

Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, Nutting C, Bushnell DL, Caplin ME, Yao JC; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):753-66. doi: 10.1097/MPA.0b013e3181ebb2a5.

PMID:
20664473
20.

NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).

Phan AT, Oberg K, Choi J, Harrison LH Jr, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):784-98. doi: 10.1097/MPA.0b013e3181ec1380.

PMID:
20664476
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk